Could High-Density Lipoprotein (HDL) Alone be a Predictive Biomarker for Patients with Erectile Dysfunction?
Journal of Innovative Healthcare Practices · 2024
DOI: 10.58770/joinihp.1435248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innovative Healthcare Practices, 2024. Verfasst von Abdullah Akkurt und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
This study aimed to assess High-Density Lipoprotein (HDL) levels as a predictor of ED in 105 men aged 20-60, to determine whether HDL levels alone could indicate Erectile Dysfunction (ED) risk independently of other factors. Despite the numerous cardiovascular risk factors associated with ED, this study uniquely focused on the predictive value of HDL levels, aiming to highlight its standalone significance in ED risk assessment. The study analyzed the interaction of HDL levels with variables such as BMI and smoking status to improve understanding of lipid profiles in assessing and managing ED Logistic regression was conducted to assess the link between low HDL levels (
Zitieren
APA
Akkurt, A., Kazan, E., & Nas, C. (2024). Could High-Density Lipoprotein (HDL) Alone be a Predictive Biomarker for Patients with Erectile Dysfunction?. Journal of Innovative Healthcare Practices. https://doi.org/10.58770/joinihp.1435248
Vancouver
Akkurt A, Kazan E, Nas C. Could High-Density Lipoprotein (HDL) Alone be a Predictive Biomarker for Patients with Erectile Dysfunction?. Journal of Innovative Healthcare Practices. 2024. doi:10.58770/joinihp.1435248
BibTeX
@article{Akkurt2024,
author = {Akkurt, Abdullah and Kazan, Ercan and Nas, Cemal},
title = {Could High-Density Lipoprotein (HDL) Alone be a Predictive Biomarker for Patients with Erectile Dysfunction?},
journal = {Journal of Innovative Healthcare Practices},
year = {2024},
doi = {10.58770/joinihp.1435248}
}
EUVIMED